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This article examines how the biomedical industrial complex has
ensnared social work within a foreign conceptual and practice
model that distracts clinical social workers from the special assistance that they can provide for people with mental distress and
misbehavior. We discuss: (1) social work's assimilation of psychiatric perspectives and practices during its pursuit of professional
status; (2) the persistence of psychiatric hospitalizationdespite its
coercive methods, high cost, and doubtful efficacy; (3) the increasing reliance on the Diagnostic and StatisticalManual of Mental
Disorders, despite its widely acknowledged scientific frailty; and
(4) the questionable contributionsof psychoactive drugs to clinical
mental health outcomes and their vast profits for the pharmaceutical industry, using antipsychotic drugs as a case example. We
review a number of promisingsocial work interventions overshadowed by the biomedical approach. We urge social work and other
helping professions to exercise intellectual independence from
the reigning paternalistic drug-centered biomedical ideology in
mental health and to rededicate themselves to the supportive, educative, and problem-solving methods unique to their disciplines.
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According to the National Association of Social Workers
(NASW), clinical social workers mainly focus on "the mental,
emotional, and behavioral well-being of individuals, couples,
families, and groups," are essential in settings such as health
centers and hospitals, substance use treatment programs,
schools, agencies for children or the aged, employee assistance
programs, and private practice, and "represent the largest
group of behavioral health practitioners in the nation" (2005,
p. 7). Based on data from the U.S. Bureau of Labor Statistics
(2010) and Whitaker and Arrington (2008), one can estimate
that approximately 40% of the 642,000 social workers in the
U.S., or 255,000 individuals, practice clinical social work.
Over the past three decades, the medicalization of distress
and misbehavior has exploded. In professional and popular
forums, problems previously attributed to environmental,
social, and personal factors-such as poverty, disintegration of
family and community, grueling work, and abusive or neglectful childhoods-have been increasingly attributed to brain dysfunctions stemming from as-of-yet-unconfirmed genetic and
chemical defects (Conrad, 2007; Moynihan & Cassels, 2005).
Some studies suggest that social work education and practice
shifted from understanding how personal-historical-ecological-contextual factors may bring about behavioral problems,
to viewing severe distress and disability as manifestations of
biological diseases defined by the successive editions of the
Diagnostic and Statistical Manual of Mental Disorders (DSM)
(Lacasse & Gomory, 2003). The shift is accompanied by clinical
social workers' use of descriptive psychiatric labels as explanations for their clients' problems (Frazer, Westhuis, Daley, &
Phillips, 2009) and, in academic social work writings, by an apparent acceptance and a dearth of critical analyses of the worth
of psychotropic drugs (Cohen, 2010). For certain authors, some
of these developments indicate that clinical social workers are
appropriately "making research-based assessments of mental
illnesses etiology" (Walsh, Green, Matthews, & BonucelliPuerto, 2005, p. 43). We argue otherwise in this paper, suggesting that the redefinition of the causes of disturbing behavior
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along the lines of current psychiatric practice is part of a larger
ideological and institutional project that is only loosely tied to
science. We also argue that it has narrowed the options of clinical social workers and other helping professionals.
Professional validation and survival might appear as
motives for clinical social work's turn to the view that serious
distress, psychosocial disability, and misbehavior are manifestations of somatic problems requiring primarily medical solutions. In this era of relative retrenchment of federal and state
spending away from human services and toward health care
(Bielefeld & Chu, 2010), the activities of social workers would
continue to benefit from official standing and public and thirdparty funding within the biomedical-industrial complex and
existing welfare state.
When Relman (1980) introduced the phrase "biomedical
industrial complex" to echo President Dwight Eisenhower's
famous 1960 warning about the influence of the military-industrial complex, he wished to emphasize the influence of
large corporations on the medical system. Later writers, focusing on its psychiatric portion or counterpart and emphasizing
its ideological elements, such as medicalization, described a
mental health-industrial complex (Duhl, Cummings, & Hynes,
1987), a psychiatric-industrial complex (Carpenter, 2001), or
a psychopharmaceutical-industrial complex (Breggin, 1997;
Murray, 2009). In accord with these authors, we use the term to
refer to the reinforcing and interlocking connections between
the pharmaceutical, biotechnological, and medical industries
that-together with academic experts in the helping professions, governmental funding and regulatory bureaucracies,
such as the National Institute of Mental Health (NIMH) and
the Food and Drug Administration (FDA), and professional
and family lobbies-promote and support a biomedical model
of psychosocial distress and disability. Spending in the U.S. on
mental health and substance abuse has been forecast to reach
$239 billion by 2014, of which $72 billion is expected to be for
psychotropic drugs (Levit et al., 2008).
Critics of the biomedical complex observe that over the
past fifty years it has monopolized mental health practices
to the detriment of its ostensible beneficiaries. Its primary
purpose seems to be "biomedical dominance" (Carpenter, 2001,
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p. 70), the successful inculcation of the view that a medicalized approach (conceptual, scientific, clinical, institutional) to
psychosocial distress, disability, and disapproved behavior is
valid and is the best approach for everyone. Critics document
that the approach obscures the differential benefits accruing
especially to the leading players, theorized in most discussions
to be large private corporations (especially but not exclusively
pharmaceutical) and their allies in politics, the professions,
and academia. These benefits translate into money, and therefore influence to recast all the issues involved, "to the extent of
altering public perceptions as to what is occurring and why"
(Turnock, 2009, p. 136). Some policy analysts have noted how
heads of corporations benefit lavishly but illicitly from the biomedical industrial complex (e.g., Cassels, 2009), and at least
one clinician (Murray, 2009), has argued that the psychopharmaceutical-industrial complex leads many clients to adopt
and internalize "disease-model messages ... in ways similar

to cult indoctrination" (p. 283), that is, impervious to evidence
and experience. These observations illustrate the complexity
of the system; they are not meant to promote a conspiracytheory-type of explanation. Our use of psychiatric-industrial
complex and associated terms is meant to re-focus attention of
social workers on the explicit and implicit functions and on the
dynamic nature of a very large social system, and of their roles
in it. It is also meant to highlight interconnections between the
constituent ideologies, professions, client populations, treatments, and institutions of the system, as well as connections
between it and other large systems, such as criminal justice,
welfare, education, and the military.
This paper's purpose is to examine and critique the biomedical industrial complex's power to define the nature,
causes, and responses to psychosocial distress, disability, and
disapproved behavior as physical diseases. It also posits that
this unopposed authority threatens the well-being of distressed
persons and suppresses innovative solutions to the perennial
challenge of disturbing behavior that might not comport with
this belief. Social workers delivering clinical services, by and
large, have sought to align with and assimilate within psychiatry's explanatory framework without carefully analyzing its
assumptions and outcomes. We think this has led to a loss of
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intellectual and practical independence among social workers.
In the hope of spurring readers to scrutinize existing systems
of care and their compatibility with the values of social work,
we review clinical social work's ancillary role to psychiatry
and discuss the contemporary functions of the psychiatric hospital, of the DSM, and of psychoactive medications as elements
in the modern psychiatric-industrial complex. We conclude by
offering suggestions for social workers and other professional helpers considering employment in or currently working
in mental health systems. In this paper we synthesize and
analyze research and evidence culled from the publicly available mainstream literature. We are puzzled that we have not
found previous academic social work publications highlighting the enormous threat that, in our judgment, scientifically
untenable claims of the psychiatric-industrial complex present
to both the well-being of our clients and to the professional
independence and effectiveness of clinical social workers.
When we use terms such as mental disorder and mental
illness in this paper, we simply refer to the many different
behaviors that have become the targets of the mental health
care system. We imply no agreement with the idea that these
problems are at root biological, that they represent distinct
clinical entities as characterized by the DSMs since 1980, or
even that they should be separated conceptually as psychopathology from other problems of living. We think that they
include at least two broad types of problems that should be
distinguished, although people often manifest both simultaneously. On the one hand, there is distress: usually situational,
life-stage-related difficulties in coping with life's demands that
manifest as impairments in personal or interpersonal functioning, and for which people seek or accept help. On the other
hand, there is misbehavior: deviant, offensive or socially disruptive behaviors that mobilize social groups to restrain the uncooperative individual. Failure to distinguish between these
two categories and the differential societal response to each,
conflates the perhaps empirically irreconcilable dual mandates
to help clients and protect society under the single rubric of
"mental health practice." This categorical mistake of not distinguishing therapeutic engagement from coercive police or
managerial authority has long been a cause of ethical dilemmas
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faced by public psychiatric social workers. It also fits with the
recent patterns of transformation of the psychiatric-industrial
complex following the downsizing of the large state mental
hospitals during the 1970s and beyond.
Social Work's Historical Alliance with Psychiatry
When a shift occurred from the universal explanatory paradigm of religion to that of science in the 17th and 18th centuries, American society also began to view dependence and
charity more rationally and critically, and by the 19th century
took "steps toward a science of social welfare and a profession
of social work" (Leiby, 1978, p. 43). This paralleled the development of almshouses, reformatories and hospitals as more
humane and efficient institutions to deal with dependent populations, including the insane. The first almshouse in America
was built in Boston in 1662, the first hospital in Philadelphia in
1752, and the very first hospital exclusively for mad people in
Williamsburg, Virginia in 1773 (Grob, 1973).
The development of insane asylums took a sharp turn in the
mid-1800s, when Dorothea Dix, a social reformer appropriated
as a pioneer both by social work and psychiatry, championed
the creation of state-run institutions for the insane as alternatives to detaining them in penal institutions. Building upon
her claim that insanity was "as curable as a cold or a fever"
(cited in Scull, 1981, p. 156) if managed according to the principles of moral treatment (a combination of detention, labor,
and re-education), she aggressively lobbied state legislatures
for funds to build public insane asylums (Lightner, 1999), and
32 state mental hospitals were founded or enlarged as a result
of her efforts (Leiby, 1978). Historians agree that Dix "was not
above employing exaggerated rhetoric or embellishing facts"
(Grob, 1994, p. 47) and that her statistics were inaccurate and
unreliable (Rothman, 1990). Gollaher (1995, pp. 434-437) has
shown how some then contemporary critics could be withering of the asylum movement and of Dix's uncritical promotion
of it. The mostly well-intended actions of Dix and her allies,
the emerging 19th century medical superintendents of insane
asylums, and the uses they made of data are early examples
of reforms and paradigm shifts in mental health justified on
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the basis of largely (but not universally) uncritically accepted
outcome claims made by social reformers and others to gain or
extend professional turf (Abbott, 1988).
Eventually, any therapeutic value of moral treatment and
its environment, the asylum, could no longer be sustained.
When Dix began her campaign in the early 1840s, less than
3,000 people lived in public and private asylums. Fifty years
later, there were 74,000 residents just in the public facilities
(Whitaker, 2002). The latter population grew to consist of the
mad, the syphilitics, the alcoholics and the senile elderly, inexorably turning the system away from curing to warehousing. This development paralleled the medicalization of these
institutions (Whitaker, 2002, ch. 2).
It is well known that "social work is one of society's tools
for securing conformity and controlling deviant individuals
and groups" (Hutchinson, 1992, p. 126). Psychiatry, however,
has been the prominent profession for these social management purposes. Much like psychiatry, social work, from its
origin, focused on social pathology and used paternalistic
interventions. Both groups skirmished with neurologists and
the nascent applied psychologists in the early 20th century for
professional control of "the Personal Problems Jurisdiction"
described by Abbott (1988, pp. 280-314). Neither group had
genuine scientific techniques of their own, but psychiatry
won out because, on the basis of its historical identification
as a medical specialty, it drew upon the age-old tradition and
emerging breakthroughs of physiological medicine. More important, by using coercion and detention and defining them
as treatment, psychiatry acquired an indispensable function in
mutating societies increasingly based on the rule of law: the
extra-legal incarceration of the insane and adult dependent
populations-a management function that has remained intact
to this day. In this endeavor, clinical social workers were relegated to being psychiatry's "handmaidens," probably because
most practitioners were women and, as Abraham Flexner
told them in 1915, lacked sufficient educationally transmissible techniques and individual responsibility in their work to
qualify as professionals (Trattner, 1979).
The effort to become a full-fledged profession provided incentives for social work to value its association with
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psychiatry and to utilize the latter "as an important working
model and standard of comparison" (Lubove, 1983, p. 55). One
can imagine that pioneer social workers did not wish to be
psychiatrists and anticipated a rational, scientific social work
profession whose practitioners worked for the moral, physical, and social betterment of deprived individuals, families,
and groups. But it is difficult to imagine that they could look
elsewhere than to psychiatry-with its mix of authoritarianism, history taking, advice giving, and medical language, for
example-as they sought professional status. The alignment
provided both a semblance of a scientific approach to enhance
social work's hoped-for professional clout, and actual settings
that could hire social workers. But it also led to social work's
subordination to psychiatric authority and to its subsequent
direct role in coercing clients, as no recognizable contractual
psychiatry yet existed. Already by 1906, Dr. James J. Putnam
of Boston's Psychopathic Hospital hired social workers to visit
patients' homes and establish "friendly relation[s]" with them
and their families "as a means of making [the physician's] directions to them effective" (Lubove, 1983, p. 63). (Putnam's use
of social workers to extend psychiatric influence in the home
of the client is a precursor to today's coercive assertive community treatment used with the severely mentally disturbed
[see Gomory, 2005]).
Perhaps more than anyone, the pioneer social worker Mary
Richmond cemented the intellectual alliance of social work
with psychiatry by developing the notion of individual treatment (casework), the sine qua non of the profession. According
to Lubove (1983), Richmond "singled out the combination of
Juvenile Court and Psychopathic Institute (along with charity
organization and medical social work) as decisive factors in the
evolution of casework" (p. 45). This further identified social
work intervention with paternalism, the medical model, and
medical settings (Kirk, Siporin, & Kutchins, 1989, pp. 296-297).
In her classic Social Diagnosis, a major response to Flexner's
charges, Richmond (1917) changed the name of caseworkers' method from investigation to diagnosis, in order "to make
advances toward a professional standard" (Richmond, 1917,
p. 26). Struggling for professional acceptance, social workers
strove to resemble medicine, by doing diagnosis and treatment
rather than investigations.
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A number of social work academics have argued that
during the middle decades of the century, "[tlhe hunches and
hypotheses of Freud, Jung, Rank and Adler combined to stimulate ... [a] 'psychiatric deluge' in social work" (Reamer, 1992,

p. 14). This argument is misleading if it implies that psychiatric influence was not always present in clinical social work, or
that the latter was unique in being strongly influenced by psychoanalytic ideas. Although many clinical social workers at
that time tried to direct their gaze to inner personality dynamics, as psychoanalytic theory requires, these practitioners also
applied the gamut of psychiatric approaches, as they had in
earlier decades (Alexander, 1972). Undoubtedly, some clients
benefitted. But in the service of social control, casework also
led to stigmatizing of some clients' lives and behavior (Dolnick,
1998). Margolin (1997) cites striking passages from several articles in social work journals in the 1960s where, especially if
they were poor, clients were described by social workers as
both emotionally and morally undeveloped.
Fifty years later, the mental health system has vastly expanded in breadth and depth. Today's psychiatric deluge in
clinical social work is still about psychiatric thinking-although within a therapeutic landscape now dominated by
psychoactive drugs.
Psychiatric Hospitals and Inpatient Treatment
Like any social reform, Dorothea Dix's campaign for building state mental hospitals had unanticipated consequences. Instead of ameliorating the difficulties of the mad, state
asylums evolved into large warehouses for society's unwanted. Their population rose from 332,000 in the early 1930s to
559,000 twenty years later (Mechanic, 1990). Although much
care of the people diagnosed with severe mental disorders
did shift to the community starting in the late 1960s, in one
of the largest shifts in American mental health policy, it continued to advance physical treatments for dimly understood
and presumed diseases of the nervous system. Assumptions
that governed the old state hospital treatments continue to undergird new community mental health services. Indeed, one
key justification for implementing the previously mentioned
assertive community treatment was that it would serve as a
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"hospital without walls" (Bond, Drake, Mueser, & Latimer,
2001, p. 146).
Today, the psychiatric units of medical-surgical hospitals
have become the major mental health crisis centers of the nation.
In the latest available data as of this writing, Manderscheid
and Berry (2006, p. 205) report that 50% of the 2.2 million psychiatric inpatient admissions, readmissions, and returns from
leave in 2002 took place in non-federal general hospitals while
only about 11% occurred in state and county mental hospitals.
So, while policy makers, professionals, and the public saw the
need for the institutional reform of the state hospital system
and community mental health treatment, the interplay among
the various elements of the biomedical-industrial complex,
along with the continued need to manage this population, has
led to a system of care that is today more medical in both approach and setting.
Just as the former state hospitals relied on the unique
state-sanctioned power of psychiatrists to force people into
locked wards, psychiatric crisis management today also rests
substantially on coercion. In this connection, it is important
to note that American national data on involuntary psychiatric examinations and detentions are extremely sparse. Using
the Medline database, we could not locate a single such study
published in the last 20 years, and our queries to national
experts were similarly unsuccessful. This absence possibly
contributes to misperceptions concerning the actual extent of
involuntary psychiatric interventions. Using 2006 involuntary
detention data for adults from California (California Health
& Human Services Agency, 2009) and 2006 involuntary psychiatric examination data for adults in Florida (Christy, 2007),
we found a very similar rate for both activities (44.6 and 49.3
per 10,000 persons in Florida and in California, respectively).
Extrapolating from the lower figures, we estimate that 1.37
million people are subjected to involuntary psychiatric detention in the U.S. in a given year. This would mean that 62% of
the nation's annual 2.2 million psychiatric inpatient admissions, readmissions, and returns from leave are officially involuntary (in addition to an unknown proportion of officially
voluntary hospitalizations).
Inpatient treatment, based on 24-hour-a-day medical
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care and a hospital infrastructure, is a costly undertaking. It
absorbed $41.4 billion of the 100.3 billion, or 41%, spent on
mental health treatment in 2003, the latest year for which data
are available (Manderscheid & Berry, 2006; Levit et al., 2008).
However, less than 1% of the general population will ever be
hospitalized (Bourdon, Rae, Narrow, Manderscheid, & Regier,
1994). Among the misallocation of current resources to these
facilities that may require reconsideration is the utilization
of professional social workers. In 1986, with approximately
218,000 inpatient residents, 21,000 social workers provided
services at these facilities. By 2000, however, with only 139,000
inpatient residents, the number of social workers employed
had almost doubled to 37,000 (Manderscheid & Berry 2006,
p. 213). Perhaps there are good reasons for this apparently
disproportional employment of social workers in coercive inpatient settings-good pay and benefits, more serious problems of the current hospitalized population requiring higher
worker-to-client ratios-but we have found no discussion in
the social work literature of either the questionable ethics of
the use of coercion or of the potential misallocation of clinical
social workers.
Given the routine application of force for hospitalization
and treatment compliance, and the disproportionate share
of mental health funds and professional services funneled
toward such a small segment of the population, one might
expect to find compelling data showing that psychiatric hospital treatment improves the lives of patients. This is not the
case (Kiesler & Simpkins, 1993; Pfeiffer, 1990; Pottick, Hansell,
Gaboda, & Gutterman, 1993). An extensive review by Kiesler
and Sibulkin (1987) of randomized controlled studies conducted from 1967-1979 comparing mental hospitalization to some
alternative intervention found no differences or the alternative outperforming hospitalization on outcomes of readmission, psychiatric symptoms, employment, social functioning,
and patient satisfaction. To our knowledge, no similar comprehensive systematic review has been published since Kiesler
and Sibulkin's. However, more recent research comparing
inpatient psychiatric hospitalization to day hospital/crisis
respite care (Sledge et al., 1996), a Soteria-like alternative residential program (Fenton, Mosher, Herrell, & Blyler, 1998), a
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consumer-managed residential program (Greenfield, Stoneking, Humphreys, Sundby, & Bond, 2008), and a variety of
community-based services (Lloyd-Evans, Slade, Jagielska, &
Johnson, 2009), also failed to demonstrate superior outcomes
for inpatient hospitalization as compared to less-restrictive
and usually consumer-preferred alternatives.
In sum, though it serves only a tiny fraction of troubled
persons in our country and alternatives have been shown to
produce better outcomes for patients, inpatient hospital treatment takes almost half of the over 100 billion dollars of annual
mental health spending in the modern mental health system.
More importantly, and less discussed, psychiatric hospitalization continues to be made possible by explicit coercion, a problematic ethical and political issue that is difficult to examine or
discuss comprehensively, due to the paucity of available data.
These considerations undermine the argument that it constitutes a value neutral, science/evidence-based form of medical
treatment.
The DSM and the Political Economy of Social Work
The Diagnostic and Statistical Manual of Mental Disorders
(DSM) of the American Psychiatric Association (APA) is the
"bible" for mental health professionals. Insurance companies
and managed-care organizations require its codes and diagnoses for reimbursement or payment of mental health services.
Is this because the DSM constitutes a valid diagnostic tool to
identify mental disorders? Clearly not. The 1980 DSM-III was
created by the neo-Kraepelinian branch of American psychiatry, strictly adhering to the view that psychiatry is a branch
of medicine that deals with people who are physically sick,
that distinct boundaries exist between mental disorder and
normality, and that diagnostic systems needed codification
to improve reliability and validity (Klerman, 1978). However,
when the APA in 2002 explained the need for a fifth revision
of the manual, it acknowledged the lack of any evidence supporting claims of biological etiology of mental disorders in the
interval: ... the goal of validating these syndromes and discovering common etiologies has remained elusive. ... [N]ot one

laboratory marker has been found to be specific in identifying
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any of the DSM-defined syndromes (Kupfer, First, & Regier,
2002, pp. xviii-xix).
The Chair of the DSM-1V Task Force, Allen Frances (2009),
repeated the assessment verbatim when commenting on the
upcoming DSM-V slated for publication in 2013:
The

incredible

recent advances

in neuroscience,

molecular biology, and brain imaging . . . are still

not relevant to the clinical practicalities of everyday
psychiatric diagnosis. The clearest evidence supporting
this disappointing fact is that not even one biological
test is ready for inclusion in the criteria sets for DSM-V.
(p. 1)
Building on the lack of gold standard validity for DSM categories, a compelling conceptual and empirical literature critical of the DSM has accumulated in all the helping disciplines.
The DSM's criteria for distinguishing mental disorder from
normality are critiqued for being undefined and tautological
(Jacobs & Cohen, 2004, 2010), and the manual is faulted for
having impoverished the study of distress and misbehavior
(Andreasen, 2007), for emphasizing the diagnosis rather than
the client's story (Tucker, 1998), for the marginal improvements in reliability produced by the DSM-III and successors
(Kirk & Kutchins, 1994), for its categories' lack of fit with observed distress in individuals (Mirowsky & Ross, 2003), for its
persistent gender and class biases (Caplan & Cosgrove, 2004),
for the frankly political processes by which categories are included or excluded from it (Caplan, 1995), and for the financial
ties between the pharmaceutical industry and DSM Task Force
members (Cosgrove, Krimsky, Vijayaraghavan, & Schneider,
2006).
Despite the consensus concerning the fragile scientific
basis of the DSM and its mostly cultural and political accomplishments, a content analysis of 69 syllabi of psychopathology
courses in schools of social work found that only six (8.5%) assigned any literature which critiqued the reliability and validity of the DSM (Lacasse & Gomory, 2003). This is ironic, since
the two strongest critics of the DSM are social work academics
Stuart Kirk and Herbert Kutchins, who have argued in many
articles and books that the much-touted improvements in
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reliability promised by the DSM rest on "flawed, incompletely reported, and inconsistent" evidence, and that the DSM's
success can only be understood by analyzing "the politics and
management of science" (1992, pp. 15-16). No scholarly work
has invalidated this critique; it has only grown substantially.
The DSM nonetheless remains the only well-accepted tool
for billing mental health services, which makes sense given its
functions in the psychiatric-industrial complex. It is published
by the profession officially owning the problem of mental
illness, which it defines. It enables the conduct of clinical trials
which are predicated on the existence of distinct mental disorders-for which the FDA grants pharmaceutical firms an
exclusive patent to market branded psychoactive drugs, most
of which reap revenues in excess of $1 billion per year shortly
after marketing. A DSM diagnosis also serves as a necessary
condition for a wide range of services and resources, especially as federal funding for social services decreases and that for
health services increases (Smith, 2010). For these reasons, the
manual serves both as economic incentive and constraint on
mental health professionals (Kirk &Kutchins, 1988). In a recent
survey of clinical social workers, 86% stated they gave a DSM
diagnosis "often to always," 94% citing insurance reimbursement as the main reason to do so (Frazer et al., 2009), with half
of respondents stating that they would not use the DSM if they
were not required to do so. Despite its profound limitations
and its completely uncertain benefits for the day-to-day work
of helping distressed clients (Caplan & Cosgrove, 2004), the
DSM remains an indispensable component of the technology
and education of the helping professions for one reason: it reflects a medical view of distress and misbehavior.
Psychiatric Medications and
the Pharmaceutical Industry
The biomedical model holds that distress and misbehavior
are bodily diseases and must be treated as such. Supporters
of the model promote it as objective scientific knowledge.
Believing that the model is valid has important political and
economic ramifications, including broadened rationales for
forced treatment (since disease implies non-responsibility) and
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allocating public resources for palliating distress according to
medical or psychiatric criteria (Olsen, 2000). Importantly, the
model has helped to consolidate the pharmaceutical industry
as the leading player in the mental health system. In turn, the
industry promotes the model as naturally suited to the concerns of the professions and the public. This has been a boon
to expand markets for branded drugs, and drugs' popularity
in turn promotes the legitimacy of the model and relieves its
adherents from producing the hard evidence needed to validate it scientifically. Despite extremely dubious contributions
of drugs in improving indicators of mental distress in comparison to the pre-drug era (Healy, 2008; Whitaker, 2010), it remains
controversial to question the status of a drug prescription as
the paradigmatic healing intervention in mental health.
Consider the case of the antipsychotic drugs. These have
been the primary psychiatric treatment for psychosis since the
1950s. When their extraordinarily burdensome adverse effects
and limited longer-term therapeutic benefits became too consequential to ignore-and useful to emphasize in promoting
the next wave of drugs-a group of second-generation, or
atypical, drugs was introduced starting in 1989 and promoted
to clinicians and patients as a decisive advance in the treatment of schizophrenia. However, their clinical trials were filled
with deliberate confounds, which made assessing the drugs'
utility difficult (Cohen, 2002). Duplicate data were published
in multiple articles, confusing the picture of how many clients
had been studied and inflating the drugs' perceived efficacy
(Huston & Moher, 1996). When manufacturers detected problems-such as the tendency of olanzapine to cause extreme
weight gain-they withheld the information and claimed the
contrary (Dyer, 2007). They made concerted efforts to influence
physicians to prescribe the drugs for off-label purposes (Brody,
2007) by individual detailing and continuing education activities, while researchers enmeshed in financial conflicts of interest
created "evidence-based guidelines" recommending the drugs
(Healy, 2006). The industry also provided generous funding to
groups such as the National Alliance for Mental Illness (NAMI)
(NAMI received 75% of its total donations from 2006 through
2008, or $23 million, from this source), which in turn has advocated tirelessly for liberal public funding of the drugs (Harris,
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2009). From less than $1 billion in 1995, sales of antipsychotics in the United States rose to an astounding $11.5 billion in
2006 (Wilson, 2009), with Medicaid apparently paying for 69%
(Waters, 2007), mostly for off-label prescriptions for which the
FDA had not considered any clinical trials and for which the
drugs had not been approved.
In 2005, the large NIMH-funded Clinical Antipsychotic
Trials of Intervention Effectiveness (CATIE) trial found that
the generic 1950s drug perphenazine (about 9 a dose) was as
efficacious as the newer antipsychotics (about $9 a dose) and
that all antipsychotics tested were discontinued on average by
74% of clients before the 18-month study ended (Lieberman
et al., 2005). Furthermore, the newer medications offered no
superior quality-of-life (Jones et al., 2006). Commenting on his
profession's lapse in the evaluation of the newer antipsychotics, Lieberman (2006) acknowledged:
The claims of superiority for the [atypicals] were greatly
exaggerated. This may have been encouraged by an
overly expectant community of clinicians and patients
eager to believe in the power of new medications. At the
same time, the aggressive marketing of these drugs may
have contributed to this enhanced perception of their
effectiveness in the absence of empirical information.
(p. 1070)
Discussing the findings' ramifications for public policy and
spending, Rosenheck, Leslie, and Doshi (2008) contextualized
the annual spending on the newer antipsychotics:
... the additional cost of using these [rather than older
drugs] ... is substantially greater than the $8.5 billion
total income of all 47,000 U.S. psychiatrists ... , could

fund 150,000 case managers [for] 1.5 million additional
consumers-or could support three times the total
number of social workers currently employed in the
United States. (p. 516)
In 2008 and 2009, several states and the Federal government
launched suits against drugmaker Eli Lilly for illegal marketing of Zyprexa (olanzapine) and other drugs for off-label indications, resulting in the largest corporate fine in U.S. history,

Clinical Social Work and the Biomedical IndustrialComplex

151

$1.4 billion. Observers were quick to note that Zyprexa's sales
that year alone were over $4 billion. By mid-2009, major fines
had been imposed on the makers of most atypical antipsychotics on the market (i.e., Feeley & Fisk, 2010; Kmietowicz, 2009;
Tanne, 2010).
In recent years, books about psychoactive medications
have appeared in the social work literature (e.g., Austrian,
2005; Bentley & Walsh, 2006, Dziegielewski & Leon, 2001).
By and large, these writings strongly affirm the therapeutic
value of currently promoted medications and suggest how
social workers can facilitate their use. None of these writings, however, have analyzed the scientific or political basis
for psychiatry's unrestrained promotion of pharmacological
treatment, for example, by scrutinizing randomized controlled
trials or examining how the pharmaceutical industry influences physicians. In all these texts, claims for the advantages
of the second-generation antipsychotics are repeated without
any critical analysis. Similar presentations are made for all
newer classes of psychotropics, which seems extraordinary,
given that the so-called pharmacological revolution in mental
health is now nearly 60 years old. Along the way, psychiatric social workers did not object to the enormous transfer of
public funds to the pharmaceutical companies; we have found
no evidence that the issues described were considered by the
profession at large.
The majority of teenage foster children receive psychiatric
medications, with a sizeable minority receiving at least three
drugs per day (Zito et al., 2008). Children on Medicaid are four
times more likely to be prescribed antipsychotics than children
with private health insurance (Wilson, 2009). In child welfare,
tragic stories have emerged in which young children were
given cocktails of psychotropics died or committed suicide
(e.g., Rebecca Riley, 4 years old, Massachusetts; Gabriel Myers,
7 years old, Florida). In each of these two instances, social
workers were involved: they took children or their families to
doctors' appointments, diligently monitored the medication
intake, and even recorded drug-induced harm to the children
(Wen, 2010). Yet they had no power to effect any changes in
the systems in which they participated. These social workers
appeared to function as enforcers of a thoroughly medicalized
approach to family poverty, disorganization and distress, to
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the detriment of the unfortunate children involved (see Florida
Department of Children and Families, 2009).
On a macro level, the NASW engages in political advocacy,
but has been silent on the promotion of drugs to consumers at
the expense of psychosocial treatment or prevention programs
(Lacasse, 2005). Moreover, in 2007, NASW took money from
Jannsen in exchange for the cooperation of NASW members
in a "research project" on a recently released injectable antipsychotic, which, it was argued, was actually a thinly veiled
marketing project (Clark, 2007; Cohen et al., 2007; Wong, 2007).
That a social work organization ostensibly committed to social
justice might fulfill the role of enabler of companies which are
increasingly shown to be America's worst corporate citizens
seems truly bizarre.
From the restriction of the practice of psychotherapy to
psychiatrists as medical doctors from about 1910-1950 (Abbott,
1988, p. 302) to the recent use of drug treatments, little appears
to have changed for social workers. Not permitted to perform
psychotherapy in those early days, they cannot prescribe medications today, yet their default stance is to encourage or require
that clients accept what psychiatrists prescribe. Social workers
might assume that, although lying outside their expertise, such
interventions are benevolent and beneficial. Psychiatrists are
conceded the intellectual/ideological higher ground, based on
their presumed grasp of yet-to-be-validated theories (psychoanalysis previously, brain circuit imbalance theories of mental
disorders presently). Social workers benefit (in prestige and
salary) in both instances by supporting something medical,
but this requires them to construct the problem as a disease
inside the client, regardless of their ethical mandate and professional socialization about systemic and person-in-environment approaches. Social workers are valued by psychiatrists
for their commitment to this model, and it is not surprising that
professionally they remain the handmaidens of psychiatry. Yet
when social workers tacitly agree with the biomedical model
of human problems, their clients not only enjoy the benefits
but also suffer the consequences of this naive commitment.
Arguably, psychiatry has been subsumed as a satellite
branch of the pharmaceutical industry, with most intellectual and practical innovations centering on the introduction of new drugs, the popularization of new indications for
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existing drugs, and the expansion of DSM disorder categories
to fit drug prescription trends. Emboldened by generous financial support of its activities from the drug industry, psychiatry
presents its biomedical hypotheses in textbooks, articles, press
releases and government websites as established facts, concealing enormous definitional and logical contradictions and weak
empirical evidence for biological theories of mental disorders
(Boyle, 2002; Moncrieff, 2008; Pam, 1990, 1995; Read, Mosher,
& Bentall, 2004; Valenstein, 1998).
Material deprivation, poor parenting, interpersonal violence, and disorganized and decaying communities are strongly correlated with emotional and behavioral disturbances
(Hollingshead & Redlich, 1958; Hudson, 2005; Read, van Os,
Morrison, & Ross, 2005), but the biomedical model concedes
only minor importance to these factors. Rather than striving to
improve human relationships or living conditions to prevent
and alleviate distress and psychosocial disability (Umberson &
Montez, 2010), the biomedical complex siphons off resources
to develop and distribute more psychoactive drugs.
Displacement of Primary Clinical Social Work Functions
While clinical social workers are engaged in studying, assessing, and assigning DSM diagnoses or taking in biased accounts of psychotropic medication effectiveness and convincing clients to take their medications, they are distracted from
applying and developing their own profession's quintessential
approaches to understanding, palliating, and preventing personal distress and maladjustment. Social work's person-in-environment perspective provides an alternate framework for these
problems by focusing on: people's interpersonal, emotional,
educational, and material needs; harmful effects of deprivation, abuse, and trauma; and the benefits of supportive social
relationships, self-awareness and self-regulation, constructive
thinking and problem-solving, and other coping mechanisms.
The social work perspective primarily lends itself to an advocacy role in securing clients necessary resources and protecting
them from physical or psychological harm. This perspective
also is embodied in numerous, well-tested psychosocial interventions that help clients to gain insight into their problem
situations, teach skills and alternative behaviors to deal with
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those problems, obtain familial and other social support to
encourage healthy life-styles, and, perhaps most crucial of
all, preventive or early intervention programs that preempt
mental problems before they develop or worsen. These approaches stand in stark contrast with reductionist, biomedical
theories that locate the cause of mental disturbances and focus
treatment almost entirely within clients' neurochemistry.
Considering treatments for clients diagnosed with severe
mental disorders as an example, social workers have applied
a variety of psychoeducational techniques, such as modeling,
verbal instructions, positive reinforcement, and environmental restructuring to effectively increase clients' normative behavior and to replace psychotic responses (Wong, 1996; Wong,
Wilder, Schock, & Clay, 2004). Using cognitive-behavioral
therapy (CBT) that emphasized stress reduction and coping
strategies, social work professor William Bradshaw and his
associates (Bradshaw, 2003; Bradshaw & Roseborough, 2004)
produced large effect-size improvements in psychosocial functioning and similar magnitude reductions in severity of symptoms in patients with long histories of being diagnosed with
schizophrenia. Bradshaw's findings are partially corroborated
by results of meta-analyses showing moderately positive outcomes of CBT for persons diagnosed with schizophrenia in
other clinical studies (Pilling et al., 2002; Wykes, Steel, Everitt,
& Tarrier, 2008). Cognitive enhancement therapy, a social-cognitive intervention, has shown impressive results in clients
recently diagnosed with DSM-IV defined schizophrenia (Eack
et al., 2009). Social work researchers have also reanalyzed
outcome data and noted the successful treatment of persons
with acute psychosis in small, home-like, community-based
programs operated by nonprofessional staff with minimal
use of antipsychotic medications (Bola & Mosher, 2003; Bola,
Mosher, & Cohen, 2005).
These effective community-based programs offer a less restrictive and less costly alternative to confinement in mental
hospitals or psychiatric units of medical-surgical hospitals.
This evidence is bolstered further by evidence from an early
psychosis psychotherapy intervention program in Lapland,
Finland, which has been effective in modifying the course of
psychosis (Seikkula et al., 2000, 2006) and which likely even

Clinical Social Work and the Biomedical IndustrialComplex

155

lowers the prevalence of DSM-IV defined schizophrenia
(Whitaker, 2010), an outcome seemingly beyond reach of our
current mental health system in the U.S. However, it will be
very difficult for social workers to improve psychosocial services or deliver them to a broader span of clients as existing
mental health services, funding, and research are all centered
on a view of psychosis, severe distress and maladjustment as
developmental brain disease and the accompanying psychopharmacological treatments (Wong, 2006).
Another important approach to addressing psychosocial
distress, disability, and disapproved behavior applicable by
social workers is prevention or early intervention. Similar to
public health programs that prevent the outbreak of diseases
by promoting proper sanitation, healthy diet, vaccinations,
avoidance of toxins, and other methods, preventive mental
health programs aim to reduce participants' exposure to risk
factors and to teach participants skills to counter potentially
harmful behaviors. By intervening before problems have
become serious or have caused irreparable damage, preventive
interventions can be more humane, less expensive, have negligible adverse effects, and hold greater potential for reducing
the overall prevalence of psychosocial distress in the general
population than any type of treatment-after-the-fact (Albee &
Gullotta, 1997; Ammerman & Hersen, 1997; Blair, 1992).
A few social work researchers are taking the lead in formulating prevention and early intervention programs to preempt
the development of psychosocial problems that are precursors
to severe mental disturbances and finding evidence of efficacy. Fraser and his colleagues (Fraser, Day, Galinsky, Hodges,
& Smokowski, 2004) used a randomized design to demonstrate the effectiveness of in-home, parent training and child
social skills training to increase children's prosocial behavior,
improve self-regulation of emotions, increase contact with
peers, raise concentration and perseverance on classroom tasks,
and to reduce aggression towards other children. Hawkins
and associates (2009) conducted a large-scale controlled evaluation across 24 towns in 7 states of similar skills-building programs for youth and adolescents aimed at preventing alcohol,
tobacco, and other drug use (correlated with severe mental
disorders) and delinquent behavior. These investigators found
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statistically significant lower rates of drug use and delinquent
behavior in youth participating in the prevention programs.
In a series of studies, Lecroy designed a psychoeducational
prevention program for adolescent girls to promote appropriate gender role, positive body image, independent decision-making, assertiveness, improved peer relationships, and
seeking help when it is needed (Lecroy, 2004a, 2004b). In one
phase of his research, Lecroy (2004b) used a randomized design
to evaluate his program and found statistically significant differences in favor of the intervention group in five out of eight
outcome measures.
While promising, these programs require substantial additional research and refinement. For example, a more recent
meta-analysis of CBT applied to clients with a schizophrenia
diagnosis (Lynch, Laws, & McKenna, 2010) found results contradicting Pilling et al. (2002) and Wykes et al. (2008). In addition, the favorable findings of the Hawkins et al. (2009) have
only been partially duplicated by other investigators (Feinberg,
Jones, Greenberg, Osgood, & Bontempo, 2010; Haggerty,
Skinner, MacKenzie, & Catalano, 2007), and the statistically
significant differences obtained by Lecroy did not have large
effect sizes (Lecroy, 2004b). Nevertheless, these psychosocial prevention and treatment programs-which controlled
studies have shown to directly benefit clients and their communities-deserve considerably more attention and commitment from social workers, rather than the heavily advertised
and possibly toxic pharmaceuticals that are already omnipresent in our society.
Conclusion
We have argued that social work, early on in its professional existence, identified with psychiatry, these two professions becoming "tied to the most fundamental of society's
functions, the control of those who are identified as deviant.
The poor, the insane, the criminal, the dependent... The
possibility of injustice in such a function is clear enough"
(Reid, 1992, p. 40). We have also highlighted that, as a result
of its allegiance to institutional psychiatry, social work has
become over the past generation inextricably entangled in the
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biomedical/psychiatric industrial complex. Its medicalized
and coercive worldview has become the professional air clinical social workers breathe, making it difficult to even notice
some of the adverse consequences raised by this uncritical
cooperation. Despite the scientific failure of the medical approach to reduce human distress and misbehavior to any causative biological state, it claims an ever-greater share of public
funding to treat human distress and misbehavior as biological
diseases.
A challenge to our perspective is that the biomedical
complex provides attractive jobs for many social workers
and its ideology dominates nearly all mental health agencies.
Nevertheless, despite inducements and pressures to conform
to the biomedical doctrine, social workers must confront the
issues discussed here if they are to preserve their integrity as
members of an independent profession. It seems crucial that
social work education implement, to borrow a phrase from
Reeser and Leighninger (1990), a "specialization in social
justice." Using the moral, political, and economic beliefs with
which they resonate, students should be helped to articulate
their own vision of a just society, learn how to analyze the political, economic, and social structures of society and understand how these can oppress people, and empower themselves
to reduce or counter the influence of institutions that mislead
and oppress. Moreover, students should be helped to envision
and build the sorts of economic and political structures that
place clients' interests at the top of social workers' priority
lists. They should also develop the sort of open-mindedness
that will maintain a constantly vigilant reexamination of their
own roles within the mental health system and the empirical
claims promulgated under it. It would be naive to think that
human distress and misbehavior could be vanquished by any
socio-economic or therapeutic project, but it would be more
naive and misguided to act as an obedient ancillary profession
marching to the drumbeat of a rapacious biomedical industrial
complex.
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